2m 2m 2m 2m 2m 2m 2m
Neogenomics (NEO)
NASDAQ
$16.83-$0.15 (-0.88%)
Price as of Aug 21, 2026 7:30 PM EDT- $2.2BMarket Cap
- 157.08%1-Year Change
- Diagnostics & ResearchIndustry
Neogenomics (NEO)
$16.83-$0.15 (-0.88%)
NEO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $16.98 | ||
Change | +$0.45 (+2.72%) | ||
Open | $16.60 | ||
High | $17.07 | ||
Low | $16.21 | ||
Previous Close | $16.53 | ||
Volume | 1,139,873 | ||
30-Day Average Volume | 2,323,251 | ||
1-Week Change | 6.52% | ||
1-Month Change | 17.51% | ||
1-Year Change | 157.08% | ||
3-Year Change | 20.60% | ||
5-Year Change | -61.31% | ||
Fundamentals | |||
Shares Outstanding | 128.5M | ||
Total Assets | $1.4B | ||
Market Cap | $2.2B | ||
Enterprise Value | $2.4B | ||
Period: QTR TTM FY | |||
Revenue | $201.7M | ||
Net Income | $2.2M | ||
Free Cash Flow | $11.7M | ||
EBIT | $1.8M | ||
EBITDA | $9.5M | ||
Net Working Capital | $275.6M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | 255 | ||
Enterprise Value/Revenue | 12 | ||
P/B | 3 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | 186 | ||
Price/Operating Cash Flow | 109 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue